1. Home
  2. MYSZ vs PFSA Comparison

MYSZ vs PFSA Comparison

Compare MYSZ & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo My Size Inc.

MYSZ

My Size Inc.

HOLD

Current Price

$0.64

Market Cap

2.2M

Sector

Technology

ML Signal

HOLD

PFSA

Profusa Inc.

HOLD

Current Price

$0.55

Market Cap

2.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYSZ
PFSA
Founded
1999
2009
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.5M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
MYSZ
PFSA
Price
$0.64
$0.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
50.8K
6.8M
Earning Date
04-15-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
57.40
N/A
EPS
N/A
N/A
Revenue
$142,000.00
N/A
Revenue This Year
$41.64
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
125.40
N/A
52 Week Low
$0.50
$0.05
52 Week High
$1.65
$4.22

Technical Indicators

Market Signals
Indicator
MYSZ
PFSA
Relative Strength Index (RSI) 49.65 42.82
Support Level $0.52 $0.43
Resistance Level $0.68 $0.66
Average True Range (ATR) 0.04 0.09
MACD -0.00 -0.02
Stochastic Oscillator 30.11 13.86

Price Performance

Historical Comparison
MYSZ
PFSA

About MYSZ My Size Inc.

My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.

Share on Social Networks: